Oic Pamora denied as non-formulary by Humana?

Humana's specific coverage criteria for oic pamora are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denies a PAMORA for OIC as Non-Formulary

Peripherally acting mu-opioid receptor antagonists (PAMORAs) for opioid-induced constipation (OIC) are a relatively specialized drug class. Humana's formularies vary by plan type (Medicare Part D, commercial, Medicaid managed care), and a specific PAMORA agent may be absent from your plan's drug list or placed at a non-preferred tier that requires additional approval. A non-formulary denial reflects a plan coverage structure decision, not a determination that the drug is medically inappropriate for you.

## Why This Denial Is Appealable

Federal law gives you the right to seek a formulary exception when a covered alternative is medically inappropriate:

• Formulary exception request: You may request that Humana cover the non-formulary PAMORA at an in-formulary cost-sharing level if you can demonstrate that formulary alternatives are medically unsuitable. For Medicare Part D plans, this exception pathway is federally mandated.
• Internal appeal (ERISA §503 / ACA §2719 / Medicare Part D): If the exception is denied, file a formal appeal. Plans must conduct a full-and-fair review within regulated timelines. Medicare Part D plans have specific redetermination and Independent Review Entity pathways with federally enforced deadlines.
• External review (ACA §2719 / IRE for Part D): After internal exhaustion, or at 4 months from denial for commercial plans, an Independent Review Organization reviews the determination. For Medicare Part D, the Independent Review Entity (IRE) step is available after the plan-level redetermination.
• Expedited option: Available when standard timelines would seriously jeopardize your health.

## Documentation to Gather

1. Formulary alternative trial history: A dated list of every PAMORA or OIC-related agent on Humana's formulary that you have tried, with outcomes — including why each was inadequate, not tolerated, or contraindicated. 2. OIC diagnosis and chronic opioid documentation: Chart notes confirming the OIC diagnosis, the underlying pain condition, and the stability of the opioid regimen. 3. Conventional bowel-regimen history: Documented prior trials of non-PAMORA agents (laxatives, stool softeners) showing inadequate response before escalation to PAMORA therapy. 4. Prescriber medical-necessity letter: A letter from your physician explaining why the specific non-formulary PAMORA is medically necessary for you and why covered alternatives are not clinically equivalent. 5. FDA label: Include the prescribing information showing the drug's approved indication to confirm the request is on-label.

## Criteria-Mapping Structure

Obtain Humana's formulary exception criteria and any published coverage policy for the PAMORA class from humana.com. List each requirement. Answer each with a specific chart fact — physician name, date, source document. For Medicare Part D plans, submit on Humana's official Coverage Determination Request form, as this triggers federally mandated response timelines.

## Next Step

Confirm with your pharmacist whether any PAMORA agent is on Humana's formulary for your specific plan year. If a formulary agent exists that you have not yet tried, your physician must document why it is medically inappropriate before an exception will be granted. If none exists in the class, that strengthens your exception request.